» Articles » PMID: 34444725

Genetically Higher Level of Mannose Has No Impact on Cardiometabolic Risk Factors: Insight from Mendelian Randomization

Overview
Journal Nutrients
Date 2021 Aug 27
PMID 34444725
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

There is a handful of controversial data from observational studies on the serum levels of mannose and risks of coronary artery disease (CAD) and other cardiometabolic risk factors. We applied Mendelian Randomization (MR) analysis to obtain estimates of the causal effect of serum mannose on the risk of CAD and on cardiometabolic risk factors. : Two-sample MR was implemented by using summary-level data from the largest genome-wide association studies (GWAS) conducted on serum mannose and CAD and cardiometabolic risk factors. The inverse variance weighted method (IVW) was used to estimate the effects, and a sensitivity analysis including the weighted median (WM)-based method, MR-Egger, MR-Pleiotropy RESidual Sum and Outlier (PRESSO) were applied. Radial MR Methods was applied to remove outliers subject to pleiotropic bias. We further conducted a leave-one-out analysis. : Mannose had no significant effect on CAD (IVW: odds ratio: 0.96 (95% Confidence Interval (95%CI): 0.71-1.30)), total cholesterol (TC) (IVW: 95%CI: 0.60-1.08), low density lipoprotein (LDL) (IVW: 95%CI = 0.68-1.15), high density lipoprotein (HDL) (IVW: 95%CI = 0.85-1.20), triglycerides (TG) (IVW: 95%CI = 0.38-1.08), waist circumference (WC) (IVW: 95%CI = 0.94-1.37), body mass index (BMI) (IVW: 95%CI = 0.93-1.29) and fasting blood glucose (FBG) (IVW: 95%CI = 0.92-1.33), with no heterogeneity for CAD, HDL, WC and BMI (all > 0.092), while a significant heterogeneity was observed for TC (IVW: Q = 44.503), LDL (IVW: Q = 33.450), TG (IVW: Q = 159.645) and FBG (IVW: Q = 0. 32.132). An analysis of MR-PRESSO and radial plots did not highlight any outliers. The results of the leave-one-out method demonstrated that the links were not driven by a single instrument. We did not find any effect of mannose on adiposity, glucose, TC, LDL, TG and CAD.

Citing Articles

Gut microbiota and risk of coronary heart disease: a two-sample Mendelian randomization study.

Hu X, Fu L, Ye B, Ao M, Yan M, Feng H Front Cardiovasc Med. 2024; 11:1273666.

PMID: 38590695 PMC: 10999620. DOI: 10.3389/fcvm.2024.1273666.

References
1.
Bowden J, Del Greco M F, Minelli C, Davey Smith G, Sheehan N, Thompson J . A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med. 2017; 36(11):1783-1802. PMC: 5434863. DOI: 10.1002/sim.7221. View

2.
Bowden J, Davey Smith G, Haycock P, Burgess S . Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genet Epidemiol. 2016; 40(4):304-14. PMC: 4849733. DOI: 10.1002/gepi.21965. View

3.
Amano E, Funakoshi S, Yoshimura K, Hirano S, Ohmi S, Takata H . Fasting plasma mannose levels are associated with insulin sensitivity independent of BMI in Japanese individuals with diabetes. Diabetol Metab Syndr. 2018; 10:88. PMC: 6280490. DOI: 10.1186/s13098-018-0391-9. View

4.
Davey Smith G, Ebrahim S . 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol. 2003; 32(1):1-22. DOI: 10.1093/ije/dyg070. View

5.
Ferrannini E, Bokarewa M, Brembeck P, Baboota R, Hedjazifar S, Andersson K . Mannose is an insulin-regulated metabolite reflecting whole-body insulin sensitivity in man. Metabolism. 2019; 102:153974. DOI: 10.1016/j.metabol.2019.153974. View